Novavax Shares Get a Boost as EC Orders up to 200 Million Doses of Its COVID-19 Vaccine

  ()
Novavax Inc. shares traded nearly 19% higher after the company reported the finalization of an advance purchase agreement with the European Commission to provide up to 200 million doses of its COVID-19 Vaccine. read more >

US-Based Biopharma 'In Full Reset Mode,' Analyst Says

Research Report
  ()
An H.C. Wainwright & Co. report notes that Agios Pharmaceuticals "is rapidly rebooting and has made critical progress on various fronts." read more >

Biopharma Makes 'Solid Clinical Progress' in Q2/21

Research Report
  ()
The highlights of Oryzon Genomics' Q2/21 clinical advancements were recapped in a Roth Capital Partners report. read more >

Translate Bio Shares Rise 29% on Sanofi's $3.2 Billion Buyout Bid

  ()
Shares of Translate Bio Inc. soared to a new 52-week high after the company reported it agreed to be acquired by its collaborative partner Sanofi SA for $38 per share in cash in a deal valued at $3.2 billion. read more >

Annovis Shares Rise on Positive Phase 2 Alzheimer's and Parkinson's Disease Trial Results

  ()
Shares of Annovis Bio Inc. traded 20% higher after the company reported positive interim data from its Phase 2 clinical studies of ANVS401 (Posiphen) for treatment of Alzheimer's and Parkinson's diseases. read more >

Gene Editing May Terminate Virus Transmission, Combat Heart and Brain Disease With a Single Shot

Contributed Research
  ()
McAlinden Research Partners explores the acceleration of gene-editing technology and notes the market is poised to expand as the World Health Organization (WHO) creates new standards for companies to follow. read more >

Rritual Superfoods at Full-Throttle, Adding CVS, Amazon Along the US Distribution Superhighway

Contributed Opinion
  ()
Knox Henderson takes a close look at Rritual Superfoods and its plans to ramp up mass distribution. read more >

Biopharma Creates New Business Unit Ahead of Commercial Product Launch

Research Report
  ()
The purpose of HTG Molecular Diagnostics' new therapeutics division and early interest in the biopharma's commercial-ready Transcriptome Panel are covered in an H.C. Wainwright & Co. report. read more >

Sorrento Therapeutics Proceeds with COVID-19 Drug Treatment Trial

Research Report
  ()
The latest developments concerning Sorrento Therapeutics, its product portfolio and partners are summarized in a Dawson James Securities report. read more >

Biopharma Partners with NIH to Advance Women's Hormone-Free Contraceptive

Research Report
  ()
A Roth Capital Partners report calls this a "very cost-effective and strategic move" for Daré Bioscience. read more >

Coverage Initiated on Company with a 'Genuine Physiological Heart Replacement Therapy'

Research Report
  ()
The investment thesis for the device company Carmat, whose therapy "allows patients to live with almost normal quality of life," is presented in an H.C. Wainwright & Co. report. read more >
News Update

Rapidly Growing Virtual Healthcare Firm Adds Three New US Group Medical Practice Clients

News Update
  ()
Reliq Health Technologies advised it entered into agreements with three physician practices in Texas for its iUGO Care platform. read more >

HCA Healthcare Shares Gain 15% on Strong Q2 Performance and Raised FY Outlook

  ()
HCA Healthcare shares established a new 52-week high after the company reported a greater than 30% increase in YoY revenue in Q2/21. read more >

Expert Investing Ideas

"AGN requested a meeting with the FDA to discuss advancing ifenprodil."

–André Uddin, Research Capital Corporation


"Final results from AGN's Phase 2b COVID-19 trial are expected soon."

–André Uddin, Research Capital Corporation


"AGN is to continue a number of preclinical studies of DMT for stroke."

–André Uddin, Research Capital Corporation


"AGN [shares] are now in a vigorous uptrend."

–Clive Maund, CliveMaund.com


"VIV signed a partnership with CSA Animal Nutrition."

–Alex Koyfman, Penny Stock Millionaire


Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe
NASDAQ Biotech ARCA Pharmaceutical

Small Bio-tech Gets $17.7 Million Backing from U.S. Department of Defense to Treat SARS-CoV-2 Delta Variant

  ()
Immunome's proprietary discovery engine identifies novel therapeutic antibodies and their targets. read more >

Cytokinetics Shares Rise 41% on Positive Phase 2 Redwood-HCM Trial Data

  ()
Cytokinetics Inc. shares reached a new 52-week high after the company reported positive topline results from its Phase 2 CK-274 hypertrophic cardiomyopathy clinical trial. read more >

Zynex Shares Rise as Firm Notches Significant Q2 Order Growth and Raises EBITDA Outlook

  ()
Zynex Inc. shares traded 10% higher after the electrotherapy medical device maker reported a 247% YoY growth in orders during Q2/21 and raised the range for its EBITDA estimates in the quarter by $1.2 million. read more >